Petersen Floyd F. 4
4 · Amphastar Pharmaceuticals, Inc. · Filed Jun 5, 2024
Insider Transaction Report
Form 4
Petersen Floyd F.
Director
Transactions
- Sale
Common Stock
2024-06-03$42.65/sh−500$21,326→ 78,333 total - Award
Common Stock
2024-06-03+3,076→ 81,409 total - Award
Stock Option (right to buy)
2024-06-03+6,864→ 6,864 totalExercise: $42.25Exp: 2034-06-03→ Common Stock (6,864 underlying)
Footnotes (4)
- [F1]The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 13, 2023.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $42.26 to $42.945, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
- [F3]The reported shares are represented by restricted stock units, or RSUs, all of which vest on June 3, 2025.
- [F4]All of the shares subject to the option vest on June 3, 2025.